Portfolio company
Sinaptica Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops non-invasive neuromodulation systems for Alzheimer's patients to slow cognitive decline using personalized brain stimulation technology.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Neuromedical
This company develops non-invasive neuromodulation devices to treat cognitive impairments and Alzheimer's disease for healthcare professionals and patients.
Cognito Tx
This company develops non-invasive wearable devices using light and sound stimulation to treat patients with Alzheimer's and other neurodegenerative diseases.
Cogniguard
This company develops non-invasive vagus nerve stimulation medical devices to treat patients with Alzheimer's disease and mild cognitive impairment.
Bottneuro
Bottneuro develops personalized non-invasive brain stimulation headsets for patients with neurological conditions such as Alzheimer's disease to provide home-based therapy.
Nuuron
This neurotech company develops a digital neuromodulation therapy delivered through virtual reality headsets to treat patients with Alzheimer's disease.
Applied Cognition
The company develops non-invasive glymphatic system monitoring platforms and drug therapies for patients with neurological disorders like Alzheimer's and Parkinson's.
Neuraworx
This company develops a wearable neurostimulation device that enhances the brain's waste clearance system to treat neurodegenerative diseases and traumatic brain injuries.
Leucadia Therapeutics
This company develops an implantable medical device to restore cerebrospinal fluid flow for patients with Alzheimer's disease and mild cognitive impairment.
